cbdMD, Inc.YCBDNYSE

Revenue (LTM)

$19M

-1.5% YoY

Net Income (LTM)

$-2M

+44.8% YoY

Free Cash Flow

$-2M

Revenue CAGR (5Y)

-14.5%

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Revenue	44	35↓20.4%	24↓31.8%	19↓19.3%	19↓1.5%
Gross Profit	29	21↓29.2%	13↓36.4%	11↓16.8%	11↓0.0%
Operating Income	-20	-17↑11.8%	-9↑46.5%	-3↑65.6%	-2↑32.2%
Net Income	-23	-70↓199.6%	-23↑67.3%	-4↑83.9%	-2↑44.8%
EBITDA	-17	-14↑17.4%	-6↑55.8%	-1↑78.4%	-0↑73.2%
EPS Diluted	-19.16	-55.80↓191.2%	-13.32↑76.1%	-1.79↑86.6%	-1.09↑39.1%

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Cash & Equivalents	26	7↓74.6%	2↓73.2%	2↑36.4%	2↓7.8%
Total Current Assets	37	16↓56.1%	8↓49.6%	6↓20.8%	7↑2.5%
Total Assets	125	41↓67.3%	16↓60.3%	11↓34.7%	10↓1.5%
Total Current Liabilities	7	5↓23.6%	5↓11.6%	9↑84.5%	3↓62.9%
Total Liabilities	22	9↓56.9%	7↓23.5%	9↑20.3%	3↓62.9%
Total Equity	103	31↓69.5%	9↓71.3%	2↓78.3%	7↑268.0%
Total Debt	6	5↓19.8%	4↓24.4%	1↓65.5%	778↑61178.5%
Net Debt	-20	-2↑90.9%	2↑201.8%	-1↓162.7%	776↑65719.2%

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Operating Cash Flow	-14	-15↓6.2%	-4↑71.3%	-0↑91.8%	-1↓311.7%
Capital Expenditure	-2	-1↑70.6%	-0↑56.8%	-0↑2.5%	-0↑36.5%
Free Cash Flow	-16	-16↑4.7%	-5↑70.6%	-1↑86.0%	-2↓154.6%
Stock-Based Comp	3	1↓68.2%	0↓63.1%	0↓95.1%	0
Net Change in Cash	12	-20↓269.9%	-5↑75.0%	1↑113.3%	-0↓129.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance